Market Overview

UPDATE: Wedbush Initiates Neutral, $34 PT on Imperva on Favorable Long-Term Fundamentals

Share:
Related IMPV
PureFunds CEO Andrew Chanin Says Cybersecurity's Investment Floor Will Only Go Higher
Summit Starts Imperva At Buy, Sees 'Secular Shift' Coming

Wedbush initiated its coverage on Imperva (NYSE: IMPV) with a Neutral rating and a price target of $34.

Wedbush commented, "We are initiating coverage with a NEUTRAL rating and a $34 target based on our CY13 EV/sales analysis, supported by our DCF. We believe the LT outlook for the company is positive given its positioning as a leading player in one of the fastest growing segments of the security market, data security, which is growing at 20%+ y/y. We think security market spending, which is primarily focused on securing the perimeter, will eventually shift to a hybrid model involving the addition of data security as a complementary, but mandatory feature."

Imperva closed at $29.47 on Tuesday.

Latest Ratings for IMPV

DateFirmActionFromTo
Jul 2015Summit ResearchInitiates Coverage onBuy
Jul 2015RBC CapitalReiteratesOutperform
Jun 2015Stephens & Co.MaintainsOverweight

View More Analyst Ratings for IMPV
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color Price Target Initiation Intraday Update Analyst Ratings

 

Related Articles (IMPV)

Get Benzinga's Newsletters